Taysha Gene Therapies

IPO

Taysha GTx

Public · Dallas, United States · Founded 2020 · $275.0M raised

Headquarters
Dallas, Texas
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$275.0M
Last Round
$150.0M Venture RoundAug 2023
Rounds
3
Type
Public

About

Taysha Gene Therapies is a clinical-stage biotechnology company focused on developing AAV-based gene therapies for severe monogenic diseases of the central nervous system. Its lead program TSHA-102 targets Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies. Founded in 2020 and headquartered in Dallas, Texas, the company's management team has proven experience in gene therapy development and commercialization.

Summary

Taysha Gene Therapies is a Biotech company based in Dallas, United States, founded in 2020. It has raised $275.0M in total across 3 rounds, most recently a $150.0M Venture Round round in Aug 2023. Investors include Fidelity Management, GV and BlackRock.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundPrivate PlacementAug 2023
$150.0M

Sign up to see all 4 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Taysha Gene Therapies on Indexed.vc
<a href="https://indexed.vc/companies/taysha-gene-therapies"><img src="https://indexed.vc/api/badge/company/taysha-gene-therapies" alt="Taysha Gene Therapies on Indexed.vc" width="260" height="76" /></a>